Biote (BTMD) Equity Average (2021 - 2026)

Biote has reported Equity Average for 6 years, with the latest figure at -$53.2 million in Q1 2026.

• For the quarter ending Q1 2026, Equity Average rose 43.06% year-over-year to -$53.2 million; the trailing twelve-month figure through Mar 2026 stood at -$53.2 million (up 43.06% YoY), and the FY2025 full-year result was -$80.4 million, down 15.85% from the prior year.
• Equity Average for Q1 2026 stood at -$53.2 million, up from -$62.0 million in the prior quarter.
• The five-year high for Equity Average was $7.4 million in Q1 2022, with the low at -$134.1 million in Q3 2024.
• Average Equity Average over 5 years is -$68.2 million, with a median of -$71.0 million recorded in 2023.
• Peak annual rise in Equity Average reached 153.76% in 2022, while the deepest fall reached 4758.04% in 2022.
• Tracing BTMD's Equity Average over 5 years: stood at -$64.6 million in 2022, then soared by 31.99% to -$43.9 million in 2023, then tumbled by 160.81% to -$114.5 million in 2024, then soared by 45.85% to -$62.0 million in 2025, then gained by 14.12% to -$53.2 million in 2026.
• The last three Equity Average figures came in at -$53.2 million (Q1 2026), -$62.0 million (Q4 2025), and -$72.2 million (Q3 2025), per Business Quant data.

Peer Comparison